Skip to main content
    L

    Labcorp Holdings Inc. (LH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $372.49
    +2.01 (+0.54%)

    Market Cap: $30.08B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Labcorp Holdings Inc. (LH) Earnings: Report Dates and Results

    Updated Oct 28, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Labcorp Holdings (LH) is expected to report earnings on Feb 15, 2027. In the quarter ended Sep 30, 2026, Labcorp Holdings reported EPS of $4.78, above the $4.65 estimate. It beat the EPS estimate in each of the last 13 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    88%(35/40)
    Avg Surprise
    +10.34%
    Streak
    13 Q

    Upcoming Estimates

    Reports Feb 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$4.65
    Range$4.25 - $4.84
    18 analysts
    Revenue Consensus
    $3.86B
    Range$3.61B - $3.98B
    17 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$4.54
    Range$4.26 - $4.79
    10 analysts
    EPS Revisions
    2
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$4.61-1.5%
    60d ago$4.61-1.5%
    30d ago$4.61-1.5%
    7d ago$4.59-1.1%
    Current$4.54
    Revenue Consensus
    $3.73B
    Range$3.69B - $3.76B
    7 analysts

    Next Report

    LH has an expected report date of Feb 15, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 14.3% above the $4.07 reported for the quarter ended Dec 31, 2025.

    LH Earnings Call

    The latest LH earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, LH beat 35, missed 3 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $3.81B, up 7.0% from $3.56B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$4.78$4.65$4.49 - $4.69+2.80%Beat+14.4%140 up, 2 downOct 28, 2026$3.81B
    Jun 30, 2026$4.99$4.79$4.68 - $4.82+4.18%Beat+14.7%130 up, 2 downJul 30, 2026$3.73B
    Mar 31, 2026$4.25$4.12$3.96 - $4.35+3.16%Beat+10.7%142 up, 3 downApr 30, 2026$3.54B
    Dec 31, 2025$4.07$3.94$3.79 - $4.00+3.30%Beat+18.0%152 up, 0 downFeb 17, 2026$3.52B
    Sep 30, 2025$4.18$4.14$4.04 - $4.34+0.97%Beat+19.4%154 up, 0 downOct 28, 2025$3.56B
    Jun 30, 2025$4.35$4.16$4.08 - $4.26+4.57%Beat+10.4%152 up, 1 downJul 24, 2025$3.53B
    Mar 31, 2025$3.84$3.73$3.52 - $3.89+2.95%Beat+4.3%15N/AApr 29, 2025$3.35B
    Dec 31, 2024$3.45$3.39$3.26 - $3.50+1.77%Beat+4.5%143 up, 0 downFeb 6, 2025$3.33B
    Sep 30, 2024$3.50$3.49$3.31 - $3.65+0.29%Beat+3.6%151 up, 1 downOct 24, 2024$3.28B
    Jun 30, 2024$3.94$3.77$3.69 - $3.85+4.51%Beat+15.2%150 up, 0 downAug 1, 2024$3.22B
    Mar 31, 2024$3.68$3.48$3.30 - $3.59+5.75%Beat-3.7%150 up, 2 downApr 25, 2024$3.18B
    Dec 31, 2023$3.30$3.26$3.11 - $3.40+1.23%Beat-20.3%140 up, 0 downFeb 15, 2024$3.03B
    Sep 30, 2023$3.38$3.33$3.11 - $3.43+1.50%Beat-27.8%130 up, 2 downOct 26, 2023$3.06B
    Jun 30, 2023$3.42$3.45$3.43 - $3.77-0.87%Miss-31.0%50 up, 1 downJul 27, 2023$3.03B
    Mar 31, 2023$3.82$3.96$3.66 - $4.33-3.54%Miss-37.5%130 up, 1 downApr 25, 2023$3.04B
    Dec 31, 2022$4.14$4.14N/A0.00%In line-38.8%130 up, 1 downFeb 16, 2023$2.17B
    Sep 30, 2022$4.68$4.68$4.52 - $5.170.00%In line-31.4%142 up, 1 downOct 27, 2022$2.87B
    Jun 30, 2022$4.96$4.68$4.41 - $5.09+5.98%Beat-19.1%144 up, 0 downJul 28, 2022$2.92B
    Mar 31, 2022$6.11$6.00$4.46 - $6.85+1.83%Beat-30.5%142 up, 1 downApr 28, 2022$3.90B
    Dec 31, 2021$6.77$5.80$5.07 - $6.87+16.72%Beat-35.9%133 up, 0 downFeb 10, 2022$1.07B
    Sep 30, 2021$6.82$4.92$4.22 - $6.76+38.62%Beat-18.9%14N/AOct 28, 2021$4.06B
    Jun 30, 2021$6.13$5.62$4.83 - $6.35+9.07%Beat+138.5%13N/AJul 29, 2021$3.84B
    Mar 31, 2021$8.79$7.49$6.17 - $8.97+17.36%Beat+270.9%14N/AApr 29, 2021$4.16B
    Dec 31, 2020$10.56$8.07$6.44 - $9.33+30.86%Beat+269.2%14N/AFeb 11, 2021$4.49B
    Sep 30, 2020$8.41$5.32$3.73 - $6.53+58.08%Beat+190.0%15N/AOct 27, 2020$3.90B
    Jun 30, 2020$2.57$0.99-$0.08 - $2.10+159.60%Beat-12.3%13N/AJul 28, 2020$2.77B
    Mar 31, 2020$2.37$1.95$1.13 - $2.36+21.54%Beat-9.5%10N/AApr 29, 2020$2.82B
    Dec 31, 2019$2.86$2.80$2.76 - $2.82+2.14%Beat+13.5%15N/AFeb 13, 2020$2.95B
    Sep 30, 2019$2.90$2.85$2.81 - $2.88+1.75%Beat+5.8%16N/AOct 24, 2019$2.93B
    Jun 30, 2019$2.93$2.92$2.82 - $3.05+0.34%Beat-1.7%20N/AJul 25, 2019$2.88B
    Mar 31, 2019$2.62$2.54$2.49 - $2.59+3.15%Beat-5.8%18N/AApr 30, 2019$2.79B
    Dec 31, 2018$2.52$2.49$2.41 - $2.53+1.20%Beat+2.9%18N/AFeb 7, 2019$2.79B
    Sep 30, 2018$2.74$2.89$2.78 - $2.93-5.19%Miss+11.4%18N/AOct 24, 2018$2.83B
    Jun 30, 2018$2.98$2.92$2.72 - $3.18+2.05%Beat+20.6%17N/AJul 25, 2018$2.87B
    Mar 31, 2018$2.78$2.63$2.56 - $2.75+5.70%Beat+25.2%16N/AApr 25, 2018$2.85B
    Dec 31, 2017$2.45$2.38$2.35 - $2.43+2.94%Beat+14.0%18N/AFeb 6, 2018$2.74B
    Sep 30, 2017$2.46$2.39N/A+2.93%Beat+9.3%N/AN/AOct 25, 2017$2.62B
    Jun 30, 2017$2.47$2.41N/A+2.49%Beat+6.9%N/AN/AJul 26, 2017$2.53B
    Mar 31, 2017$2.22$2.20N/A+0.91%Beat+9.9%N/AN/AApr 25, 2017$2.41B
    Dec 31, 2016$2.15$2.13N/A+0.94%Beat+8.6%N/AN/AFeb 16, 2017$2.34B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $16.44, up 12.8% from the year before. It was $8.73 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$16.44+12.8%
    Dec 31, 2024$14.57+4.7%
    Dec 31, 2023$13.92-30.0%
    Dec 31, 2022$19.89-30.2%
    Dec 31, 2021$28.51+19.2%
    Dec 31, 2020$23.91+111.4%
    Dec 31, 2019$11.31+2.6%
    Dec 31, 2018$11.02+14.8%
    Dec 31, 2017$9.60+10.0%
    Dec 31, 2016$8.73N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,800 words across 17 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,82717
    2026Q2Jun 30, 20268,04817
    2026Q1Mar 31, 20266,46314
    2025Q4Dec 31, 20257,83614
    2025Q3Sep 30, 20256,55217
    2025Q2Jun 30, 20258,05017
    2025Q1Mar 31, 20257,90416
    2024Q4Dec 31, 20241,2699

    2026Q3 Earnings Call

    Opening remarks

    Dewey Steadman VP, Investor Relations Good morning, and welcome to LabCorp's Third Quarter 2026 Financial Results Webcast. With me today are Adam H. Schechter, our Chairman and Chief Executive Officer, and Julia Wang, Executive Vice President and Chief Financial Officer. This morning, in the events section of the LabCorp investor relations website at ir.labcorp.com, we posted both our press release and the supplemental financial presentation with additional information on our business and operations. We will also host a replay of this webcast on the IR website for one year. On today's webcast, we will focus on our adjusted non-GAAP results for the third quarter of 2026, our capital allocation strategy, and our updated financial guidance for the full year 2026. Our GAAP results and a reconciliation of the non-GAAP financial measures to the most comparable GAAP financial measures are available in today's earnings release and the supplemental financial presentation. Please see the use of adjusted measures section in the supplemental presentation for more information regarding our use of non-GAAP financial measures. In today's remarks, the term organic growth excludes the impact from acquisitions, divestitures, and currency, as well as other strategic actions taken in the early development business. Our remarks will also include forward-looking statements, including but not limited to statements about our updated 2026 financial guidance and long-term financial outlook, and the related assumptions of each; the expected impact of various factors on our business, operating and financial results, cash flows, and financial condition; global economic and market conditions; our future business strategies; the expected savings, benefits, and synergies from acquisitions and other transactions and partnerships; and our potential opportunities for future growth. Each of these forward-looking statements is subject to change based upon various factors, many of which are beyond our control. More information is included in our most recent annual report on Form 10-K and subsequent quarterly reports on Forms 10-Q and in the company's other filings with the SEC. We have no obligation to provide any updates to these forward-looking statements, even if our expectations change. Now I will turn the call over to LabCorp's Chairman and CEO, Adam H. Schechter. Adam?

    Adam H. Schechter Chairman and CEO Thank you, Dewey. Good morning, everyone. We appreciate you joining us today to review our third-quarter 2026 results. LabCorp delivered another strong quarter, with 7% revenue growth driven by volume, margin expansion across the enterprise, and 14.5% EPS growth. Our results reflect disciplined execution as we drive continued momentum in diagnostics and biopharma laboratory services. With these strong results, we are increasing our 2026 guidance. Before turning to the specifics of the quarter, I want to briefly address PAMA.

    Frequently Asked Questions About LH

    When is Labcorp Holdings's next earnings date?

    Labcorp Holdings's next earnings report is expected for Feb 15, 2027.

    Did LH beat earnings estimates last quarter?

    Yes. Labcorp Holdings reported EPS of $4.78 for the quarter ended Sep 30, 2026, above the $4.65 estimate, a 2.80% surprise.

    What EPS do analysts expect from LH next quarter?

    The consensus EPS estimate for Labcorp Holdings for the quarter ending Dec 31, 2026 is $4.65 from 18 analysts, with estimates from $4.25 to $4.84.

    How often does LH beat earnings estimates?

    Labcorp Holdings beat the EPS estimate in each of the last 13 quarters, with an average surprise of +2.84%.